Clinical Application of Opioid Equianalgesic Data
- 1 September 2003
- journal article
- case report
- Published by Wolters Kluwer Health in The Clinical Journal of Pain
- Vol. 19 (5) , 286-297
- https://doi.org/10.1097/00002508-200309000-00002
Abstract
Physicians and other healthcare professionals may often be faced with the need to change opioids during the course of a patient's opioid analgesic care due to a number of clinical reasons. The act of converting opioid analgesics, for many physicians, nurses, and pharmacists, who do not receive adequate training, remains a challenging and often uncomfortable aspect of pain treatment. Part of the challenge clinicians face is secondary to the relatively weak literature evidence base that exists to support the equianalgesic ratios provided in textbooks, journals, and other medical resources. Another aspect involves the lack of a widely recognized treatment algorithm or guideline to assist clinicians with opioid conversion. The final decision on which opioid dose to prescribe must involve a thorough clinical assessment to minimize the risk of prescribing inappropriate opioid doses over or under the patient's actual need. The purpose of this paper is to provide the clinician with an approach for dealing with the conversion between opioid analgesics that is standardized, yet allows for individualized results to meet unique patient needs. We present a 5-step process as a guide for clinicians faced with the need to change a patient's opioid regimen. This approach may help to build a comfort level when dealing with the clinical challenges of converting from one opioid to another.Keywords
This publication has 17 references indexed in Scilit:
- Accuracy in Equianalgesic DosingJournal of Pain and Symptom Management, 2001
- Opioid Equianalgesic CalculationsJournal of Palliative Medicine, 1999
- Efficacy of oxycodone in neuronathic painNeurology, 1998
- Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective studyPain, 1997
- Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer painCancer, 1997
- Clinical analgesic equivalence for morphine and hydromorphone with prolonged PCAPain, 1996
- Infection by Human Immunodeficiency Virus — CD4 is Not EnoughNew England Journal of Medicine, 1996
- Morphine and oxycodone hydrochloride in the management of cancer painClinical Pharmacology & Therapeutics, 1990
- Pain and analgesicsCurrent Medical Research and Opinion, 1978
- Clinical pharmacology of analgesics: 1. A method of assaying analgesic effectClinical Pharmacology & Therapeutics, 1960